INTRODUCTION: The national reconfiguration of vascular surgery means that arterial centres serve larger populations with increased demand on resources. Emergency general surgery ambulatory clinics facilitate timely review and intervention, avoiding admission; a critical limb ischaemia (CLI) 'hot clinic' (HC) was implemented to achieve similar for vascular patients. The aim of the study was to determine HC efficacy. METHODS: This was a prospective cohort study comparing HC patients with emergency admission (EA) patients between 1 May and 1 December 2017. Age, sex, comorbidities, CLI severity and smoking status were noted. HC patients were provided with satisfaction surveys. Primary outcome measures were freedom from reintervention and major amputation. Secondary outcome measures included time to procedure, length of stay, returns to theatre and 30-day readmission. RESULTS: A total of 147 patients (72 HC, 75 EA) were enrolled in the study. No statistical difference was found in age, sex, smoking status, severity of CLI or prevalence of comorbidities between the groups except that diabetes was more prevalent in EA patients (p=0.028). The median length of stay for the HC cohort was shorter (3 days vs 17 days, p<0.001), with no difference between time to procedure, return to theatre or 30-day readmission. HC patients were nearly 6 times more likely to experience freedom from reintervention (odds ratio: 5.824, p<0.001) and 2.5 times less likely to undergo amputation (odds ratio: 2.616, p=0.043). HC utilisation saved a total of 441 bed days. Over 90% of attendees responded with 100% positive feedback. CONCLUSIONS: A vascular HC facilitates urgent review and revascularisation. It provides comparable in-hospital outcomes and better long-term outcomes, with greater efficiency than hospital admission, demonstrating its value in treating CLI.
INTRODUCTION: The national reconfiguration of vascular surgery means that arterial centres serve larger populations with increased demand on resources. Emergency general surgery ambulatory clinics facilitate timely review and intervention, avoiding admission; a critical limb ischaemia (CLI) 'hot clinic' (HC) was implemented to achieve similar for vascular patients. The aim of the study was to determine HC efficacy. METHODS: This was a prospective cohort study comparing HC patients with emergency admission (EA) patients between 1 May and 1 December 2017. Age, sex, comorbidities, CLI severity and smoking status were noted. HC patients were provided with satisfaction surveys. Primary outcome measures were freedom from reintervention and major amputation. Secondary outcome measures included time to procedure, length of stay, returns to theatre and 30-day readmission. RESULTS: A total of 147 patients (72 HC, 75 EA) were enrolled in the study. No statistical difference was found in age, sex, smoking status, severity of CLI or prevalence of comorbidities between the groups except that diabetes was more prevalent in EA patients (p=0.028). The median length of stay for the HC cohort was shorter (3 days vs 17 days, p<0.001), with no difference between time to procedure, return to theatre or 30-day readmission. HC patients were nearly 6 times more likely to experience freedom from reintervention (odds ratio: 5.824, p<0.001) and 2.5 times less likely to undergo amputation (odds ratio: 2.616, p=0.043). HC utilisation saved a total of 441 bed days. Over 90% of attendees responded with 100% positive feedback. CONCLUSIONS: A vascular HC facilitates urgent review and revascularisation. It provides comparable in-hospital outcomes and better long-term outcomes, with greater efficiency than hospital admission, demonstrating its value in treating CLI.
Authors: Judith S L Partridge; Matthew Fuller; Danielle Harari; Peter R Taylor; Finbarr C Martin; Jugdeep K Dhesi Journal: Int J Surg Date: 2015-04-20 Impact factor: 6.071
Authors: Steven T W van Haelst; Saskia Haitjema; Jean-Paul P M de Vries; Frans L Moll; Gerard Pasterkamp; Hester M den Ruijter; Gert J de Borst Journal: J Vasc Surg Date: 2016-09-22 Impact factor: 4.268
Authors: Marlon I Spreen; Hendrik Gremmels; Martin Teraa; Ralf W Sprengers; Marianne C Verhaar; Randolph G Statius van Eps; Jean-Paul P M de Vries; Willem P Th M Mali; Hans van Overhagen Journal: Diabetes Care Date: 2016-09-09 Impact factor: 19.112
Authors: Jeffrey J Siracuse; Heather L Gill; Douglas W Jones; Darren B Schneider; Peter H Connolly; Inkyong Parrack; Zhen S Huang; Andrew J Meltzer Journal: Ann Vasc Surg Date: 2014-02-08 Impact factor: 1.466
Authors: Edward A Goka; Patrick Phillips; Edith Poku; Munira Essat; Helen B Woods; Stephen J Walters; Eva C Kaltenthaler; Phil Shackley; Jonathan Michaels Journal: Ann Vasc Surg Date: 2017-05-05 Impact factor: 1.466
Authors: Jeffrey J Siracuse; Zhen S Huang; Heather L Gill; Inkyong Parrack; Darren B Schneider; Peter H Connolly; Andrew J Meltzer Journal: Vasc Health Risk Manag Date: 2014-06-23